Revalesio Corporation's investigational therapeutic RNS60 prevented memory loss and improved learning in mouse models, according to new data the…

The Senate Appropriations Committee approved a bill Wednesday that would provide $30.95 billion in funds for the National Institutes of Health for fiscal year…

Researchers may be on their way to finding safer drugs for treatingarthritisthat don't cause potentially harmful cardiovascular side effects like some…

The U.K. could be lagging behind in regenerative medicine and missing out on opportunities to translate basic science to commercially viable treatments, a new…

Deep, across-the-board federal spending cuts--totaling $85 billion--are set to go into effect today after Congress and President Barack Obama failed to come to…

In a piece of news tucked away in its Form 8-K, troubled BioCryst Pharmaceuticals has ditched its preclinical hepatitis C virus (HCV) program of BCX5191 and…

Preclinical studies have raised a potential red flag on anti-VEGF therapies, suggesting that increasingly aggressive use in eye disease could trip off side…

Responding to pressure from animal rights activists, ferry companies and airlines in the U.K. are banning the transportation of test animals bound for…

Regulatory